Identification of Additional Trials in Prospective Trial Registers for Cochrane Systematic Reviews
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Publication and selective outcome reporting bias are a threat to the validity of systematic reviews. Extensive searching for additional trials in prospective trial registers could reduce this problem. We have evaluated how authors of Cochrane systematic reviews currently make use of trial registers as an additional source for the identification of potentially eligible trials. METHODOLOGY/PRINCIPAL FINDINGS: We included 210 systematic Cochrane reviews of interventions published between 2008 and 2010 of which the protocol was first published in 2008. When prospective trial registers were searched we recorded the names of the register(s), the authors' motive(s) and if they yielded any extra trials. In 80 reviews (38.1%) the authors had searched in one or more prospective trial register(s) of which 55% had searched in overlapping search portals and individual registers. Most frequently assessed were the MetaRegister (66.3%) and Clinicaltrials.gov (60%) which is in sharp contrast of other registers or portals like the WHO ICTRP Search Portal (20%). Reported motives to use registers were to identify ongoing trials (83.3%), to identify unpublished outcomes or trials (23.5%), to identify recently published trials (11.8%), or to identify any relevant trial (3.9%).In 28 reviews (35%) the authors had selected (ongoing) trials identified in trial registers as potentially eligible. DISCUSSION: Trial registers as an additional source of information are gaining acknowledgement amongst Cochrane reviewers. Nevertheless, searches seem to be inefficient as overlapping databases are frequently consulted, while the WHO ICTRP Search Portal that includes the data from all approved registers worldwide is being underused. Moreover, the emphasis is now on the identification of ongoing trials, although the prospective registers offer a broader potential. Further familiarity of registers and guidance how to search and to report will help to implement this as a common method and utilize the full potential of prospective trial registers for systematic reviews.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
Dwan, K., Altman, D. G., Arnaiz, J. A., Bloom, J., Chan, A.-W., Cronin, E., Decullier, E., Easterbrook, P. J., Von Elm, E., Gamble, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003081 · Cited by 1,546 · cited 1×
“Empirical evidence consistently suggests that statistically significant and positive findings are more likely to be published than non-significant or negative findings [3,4] and will take shorter time to be submitted and to get published after completion of the study [5–8].”
BackgroundThe Existence of Publication Bias and Risk Factors for Its Occurrence
Dickersin, K. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440100097014 · Cited by 1,417 · cited 1×
“Empirical evidence consistently suggests that statistically significant and positive findings are more likely to be published than non-significant or negative findings [3,4] and will take shorter time to be submitted and to get published after completion of the study [5–8].”
BackgroundClinical Trial Registration: A Statement from the International Committee of Medical Journal Editors
De Angelis, C., Drazen, J. M., Frizelle, F. A., Haug, C., Hoey, J., Horton, R., Kotzin, S., Laine, C., Marusic, A., Overbeke, A. J. P. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejme048225 · Cited by 1,241
Egger, M., Jüni, P., Bartlett, C., Holenstein, F., & Sterne, J. (2003) · Health Technology Assessment · doi:10.3310/hta7010 · Cited by 1,181
Kirkham, J. J., Dwan, K. M., Altman, D. G., Gamble, C., Dodd, S., Smyth, R., & Williamson, P. R. (2010) · BMJ · doi:10.1136/bmj.c365 · Cited by 1,133 · cited 1×
“This can affect the results from the meta-analysis of the review and possibly also the results of a review without any meta-analysis [9].”
BackgroundDissemination and publication of research findings: an updated review of related biases
Song, F., Parekh, Hooper, L., Loke, Y., Ryder, J., Sutton, A., Hing, C., Kwok, C., Pang, C., & Harvey, I. (2010) · Health Technology Assessment · doi:10.3310/hta14080 · Cited by 1,039
Publication bias: the case for an international registry of clinical trials.
Simes, R. J. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.10.1529 · Cited by 747
Ioannidis, J. P. A. (1998) · JAMA · doi:10.1001/jama.279.4.281 · Cited by 632 · cited 1×
“Empirical evidence consistently suggests that statistically significant and positive findings are more likely to be published than non-significant or negative findings [3,4] and will take shorter time to be submitted and to get published after completion of the study [5–8].”
BackgroundGrey literature in meta-analyses of randomized trials of health care interventions
Hopewell, S., McDonald, S., Clarke, M. J., & Egger, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000010.pub3 · Cited by 598
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses
Hart, B., Lundh, A., & Bero, L. (2012) · BMJ · doi:10.1136/bmj.d7202 · Cited by 255 · cited 1×
“Third, it would be very interesting to measure the effect of the inclusion of trials from prospective trial registers on the results of the review but unfortunately we had too low power (n = 4) to perform sensible analysis [25,26].”
Background
Cited by
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120
Cooper, C., Booth, A., Britten, N., & Garside, R. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0625-1 · Cited by 137
Baudard, M., Yavchitz, A., Ravaud, P., Perrodeau, E., & Boutron, I. (2017) · BMJ · doi:10.1136/bmj.j448 · Cited by 107
Jones, C. W., Keil, L. G., Weaver, M. A., & Platts-Mills, T. F. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-126 · Cited by 61
“Our results are similar to findings from an analysis of Cochrane systematic reviews published between 2008 and 2010, in which trials registry searches were only included in 38% of reviews [54].”
ResultPotthast, R., Vervölgyi, V., McGauran, N., Kerekes, M. F., Wieseler, B., & Kaiser, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092067 · Cited by 20
Metadata
- Authors
- van Enst, W. A., Scholten, R. J. P. M., & Hooft, L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-08-15
- Volume
- 7
- Issue
- 8
- Pages
- e42812
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2020248812
- Cited by
- 24
- References
- 12
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of Additional Trials in Prospective Trial Registers for Cochrane Systematic Reviews. https://app.cochat.ai/papers/10.1371/journal.pone.0042812
- The paper
- van Enst, W. A., Scholten, R. J. P. M., & Hooft, L. (2012). Identification of Additional Trials in Prospective Trial Registers for Cochrane Systematic Reviews. PLoS ONE. https://doi.org/10.1371/journal.pone.0042812
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.